Abstract: A storage assembly is provided with a pair of spaced apart brackets. A pair of hubs is each pivotally connected to one of the pair of spaced apart brackets. A rotary limit is connected to one of the pair of hubs and one of the pair of spaced apart brackets to limit the pair of hubs to a range of rotation relative to the pair of spaced apart brackets. A pair of bars is each connected to the pair of hubs to rotate with the pair of hubs to support and store articles upon the pair of bars.

Abstract: The present invention relates to a novel process for preparing chlorobenzaldehyde oximes of the general formula (I).

Abstract: A system for measuring at least one physiological parameter includes a wearable device configured to be secured to a subject's foot and a camera configured to captures images of the subject. An electronic device may be in communication with the system and can display information relating to physiological data and/or images collected by the system.

Abstract: Techniques are disclosed for managing aspects of identifying and/or deploying hardware of a dedicated cloud to be hosted at a customer location (a “DRCC”). A DRCC may comprise cloud infrastructure components provided by a cloud provider but hosted by computing devices located at the customer's (a “cloud owner's”) location. Services of the central cloud-computing environment may be similarly executed at the DRCC. A number of user interfaces may be hosted within the central cloud-computing. These interfaces may be used to track deployment and region data of the DRCC. A deployment state may be transitioned from a first state to a second state based at least in part on the tracking and the deployment state may be presented at one or more user interfaces. Using the disclosed user interfaces, a user may manage the entire lifecycle of a DRCC and its corresponding hardware components.

Abstract: Methods and systems are described herein for identifying the location and nature of any blur within one or more images received as a user communication and generating an appropriate correction. The system utilizes a first machine learning model, which is trained to identify blurred components of inputted images and determine whether the blurred components are located in portions of the inputted images comprising textual information. The system may apply a corrective action selected by the first machine learning model, which may comprise stitching blurred images together to a sharp product image and/or some other method appropriate for rectifying images received.

Abstract: A system for measuring at least one physiological parameter includes a wearable device configured to be secured to a subject’s foot and a sensor component that is removably securable to the wearable device. The wearable device includes a base configured to contact a bottom of the subject’s foot, a wall extending outward from the base and configured to surround a heel of the subject’s foot, and a sensor component that is removably securable to the wearable device. The sensor component includes a sensor hub configured to be removably secured to the wearable device, a sensor strap configured to be wrapped around the subject’s foot and secured to the wearable device, an emitter configured to emit optical radiation into tissue of the subject’s foot, and one or more detectors configured to detect at least a portion of the emitted optical radiation after passing through the tissue.

Abstract: The present invention relates to compounds of formula I as defined herein, and salts and solvates thereof, that function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity. The present invention also relates to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which Cdc7 kinase activity is implicated.

Abstract: A pulse oximetry system for measuring at least one physiological parameter includes a wearable device configured to be secured to a subject's foot, a sensor hub that is removably securable to the wearable device, and a sensor strap connected to the sensor hub and configured to be wrapped around the subject's foot and secured to the wearable device. In some implementations, the wearable device is configured such that the cavity is positioned adjacent a bottom portion of the subject's foot. The system further includes one or more emitters arranged within the sensor hub and configured to face toward said bottom portion of the subject's foot and one or more detectors arranged within the sensor strap and configured to be positioned adjacent a top portion of the subject's foot.

Abstract: A pulse oximetry system includes a wrist portion configured for placement on a wrist of a subject, the wrist portion having a first component and a second component configured to removably secure to one another. The wrist portion can include emitter(s) and detector(s) operably positioned by the wrist portion. In some implementations, the pulse oximetry system further includes a ring member configured to secure around the subject's finger and operably position emitter(s) and detector(s) and a cable connected to the wrist portion in electrical communication with the emitter(s) and the detector(s) of the ring member and configured to transmit the signal(s) from the detector(s) to the wrist portion. The system includes a battery and hardware processor(s) configured to receive and process signal(s) outputted by the detector(s) to determine physiological parameter(s) of the subject.

Abstract: Disclosed herein are seed and plants of the maize hybrid variety designated ICH39956, as well as cells and cell cultures derived therefrom. Further disclosed are methods for producing seed, commodity products, and derived progeny plants from the maize hybrid variety designated ICH39956.

Abstract: Disclosed herein are seed and plants of the maize hybrid variety designated ICH19849, as well as cells and cell cultures derived therefrom. Further disclosed are methods for producing seed, commodity products, and derived progeny plants from the maize hybrid variety designated ICH19849.

Abstract: Disclosed herein are seed and plants of the maize hybrid variety designated ICH72121, as well as cells and cell cultures derived therefrom. Further disclosed are methods for producing seed, commodity products, and derived progeny plants from the maize hybrid variety designated ICH72121.

Abstract: Disclosed herein are seed and plants of the maize hybrid variety designated ICH13881, as well as cells and cell cultures derived therefrom. Further disclosed are methods for producing seed, commodity products, and derived progeny plants from the maize hybrid variety designated ICH13881.

Abstract: The present invention concerns proteins having improved omega-transaminase (?-TA) activity, nucleic acid molecules encoding respective proteins having improved ?-TA activity and methods for stereo selective synthesis of chiral amines and amino acids or increasing of chiral amines isomers in enantiomer mixtures.

Abstract: The present invention relates to compounds of formula I as defined herein, and salts and solvates thereof, that function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity. The present invention also relates to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which Cdc7 kinase activity is implicated.

Abstract: Technology for operating a computer system to manage network communications with plural devices, comprising retrieving from a registry one or more device capability profiles for the identified devices, the registry linking a device capability profile with each of the identified plural devices and the device capability profile identifying one or more capabilities of a device; operating in the computer system a message translation manager to adapt a message according to a linked device capability profile of each of the plural devices; and sending the message in adapted form to each identified one of the plural devices.

Abstract: The present invention primarily relates to a process for producing certain substituted 2-allylanilines of the hereinbelow-defined formula (I) and their use in a process for producing substituted 4-aminoindane derivatives of the hereinbelow-defined formula (V). The present invention further relates to a process for producing fungicidal indanyl carboxamides. In particular, the present invention relates to a process for producing 2-(difluoromethyl)-N-(1,1-dimethyl-3-propyl-2,3-dihydro-1H-inden-4-yl)nicotinamide and/or 3-(difluoromethyl)-N-[(R)-2,3-dihydro-1,1,3-trimethyl-1H-inden-4-yl]-1-methylpyrazole-4-carboxamide.

Abstract: The present invention relates to a process for preparing compounds of the formula (I) starting from compounds of the formula (II) in which R1, R2 and R3 have the abovementioned meaning and where R1 and R3 are not simultaneously hydrogen in any compound. The invention further provides the compounds of the formulae (IVa), (IVb), (V) and (VI) in which R1, R2, R3, R5, M and n have the abovementioned meaning.

Abstract: The present invention relates to a process for preparing compounds of the formula (I) starting from compounds of the formula (II) wherein X, R1, R2, R3, R4, U, A1, A2, A3 and A4 are defined as described above. The invention relates to compounds of the formulae (III) and (IV) wherein all variables are defined as above.

Abstract: A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4-position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseases and malaria; and organ and cell transplant rejection.